Author

Farah Shaukat

Observed names: F. Shaukat, Shaukat, Farah

Observed institutions: University of Maryland, Baltimore, Johns Hopkins University, Johns Hopkins Medicine, Ziauddin Hospital, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, Ziauddin University

OpenAlex ID: A5081835624

Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations

2018 · Emmanuel S. Antonarakis, Farah Shaukat, et al. · European Urology · 177

Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy

2013 · M.T. Schweizer, X.C. Zhou, et al. · Annals of Oncology · 101

Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer

2019 · Pedro Isaacsson Velho, Wei Fu, et al. · European Urology · 91

UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review

2021 · Farah Shaukat, Melissa Hart, et al. · Modern Rheumatology Case Reports · 41

Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design

2021 · Lourdes R. Carhuapoma, Winter M. Thayer, et al. · Trials · 7

Tracheo-innominate fistula formation; a rare complication of tracheostomy.

2013 · Farah Shaukat, Khalid Iqbal, et al. · PubMed · 6

Dehydrated Hereditary Stomatocytosis: A Rare Inherited Hemolytic Anemia

2021 · Farah Shaukat, Zeba Singh, et al. · Blood · 3

Association of metastasis-free survival (MFS) with overall survival (OS) in men with PSA-recurrent prostate cancer treated with deferred androgen-deprivation therapy.

2013 · Michael Thomas Schweizer, Xian C. Zhou, et al. · Journal of Clinical Oncology · 3

Refractory Immune Mediated ITP in a Patient with Metastatic Melanoma

2021 · Farah Shaukat, Roopa Gupta, et al. · Blood · 2

Complete Heart Block in Pregnancy: A Curable Entity

2024 · Farah Shaukat, Shama Chaudhry, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

WNT activating pathway mutations confer resistance to first-line antiandrogen therapy in castration-resistant prostate cancer (CRPC).

2019 · Pedro Isaacsson Velho, Nooshin Mirkheshti, et al. · Journal of Clinical Oncology

Works count: 14

Citation count: 431

H-index: 6

I10-index: 4